Koizumi M, Endo K, Kunimatsu M, Sakahara H, Nakashima T, Kawamura Y, Watanabe Y, Ohmomo Y, Arano Y, Yokoyama A
Department of Nuclear Medicine, Faculty of Medicine, Kyoto University, Japan.
J Immunol Methods. 1987 Nov 23;104(1-2):93-102. doi: 10.1016/0022-1759(87)90492-3.
Radionuclides or anti-cancer drugs may be coupled to antibodies for specific transport to target tissues. We have previously reported that several proteins could be rapidly and efficiently labeled with gallium (67Ga) by using deferoxamine (DFO) as a bifunctional chelating agent. In the present paper, we have described the use of hetero-bifunctional agents for the conjugation of DFO with antibodies and investigated the effect of coupling agents on in vitro properties and biodistribution of 67Ga-labeled antibodies. 67Ga-labeled monoclonal antibodies retained antigen-binding activity when prepared under optimum conditions. The use of hetero-bifunctional reagents, such as succinimidyl 6-maleimido-hexanoate (EMCS) or N-succinimidyl-3-(2-pyridyldithio)-propionate (SPDP), which link thioether bonds and disulfide bridges prevented the formation of polymerized antibodies. Although high non-specific uptake in the liver was observed with radiolabels prepared by the homo-bifunctional agent glutaraldehyde, uptake in the liver was low with conjugates linked by hetero-bifunctional agents. 67Ga-labeled antibodies with thioether bonds showed in vivo stability, but the clearance from the circulation was the fastest with the radiolabel holding disulfide bonds. The coupling reagents used to link DFO and antibodies greatly influenced both in vitro properties and in vivo distribution of labeled antibodies and 67Ga-labeled antibodies provide a good model for the study of coupling methods and biodistribution of antibody conjugates.
放射性核素或抗癌药物可与抗体偶联,以便特异性转运至靶组织。我们之前报道过,通过使用去铁胺(DFO)作为双功能螯合剂,几种蛋白质能够被镓(67Ga)快速且高效地标记。在本文中,我们描述了使用异双功能试剂将DFO与抗体偶联,并研究了偶联剂对67Ga标记抗体的体外性质和生物分布的影响。在最佳条件下制备时,67Ga标记的单克隆抗体保留了抗原结合活性。使用诸如己二酸6-马来酰亚胺基琥珀酰亚胺酯(EMCS)或N-琥珀酰亚胺基-3-(2-吡啶基二硫代)丙酸酯(SPDP)等形成硫醚键和二硫键桥的异双功能试剂,可防止抗体聚合。尽管通过同双功能试剂戊二醛制备的放射性标记物在肝脏中观察到较高的非特异性摄取,但通过异双功能试剂连接的偶联物在肝脏中的摄取较低。具有硫醚键的67Ga标记抗体在体内表现出稳定性,但具有二硫键的放射性标记物从循环中的清除速度最快。用于连接DFO和抗体的偶联试剂对标记抗体的体外性质和体内分布都有很大影响,并且67Ga标记抗体为研究抗体偶联物的偶联方法和生物分布提供了一个良好的模型。